Target intelligence / Profile preview

Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ)

Target
IKKβ
Molecular classification
Enzyme, Serine/threonine protein kinase
01

Overview

IKKβ is a serine/threonine protein kinase and a key regulatory subunit within the IκB kinase (IKK) complex. It is essential for the canonical NF-κB signaling pathway, activated by diverse stimuli like inflammatory cytokines, microbial products, and stress signals. Upon activation, IKKβ phosphorylates IκBs, leading to their degradation and subsequent NF-κB translocation into the nucleus to activate genes involved in immune response, inflammation, cell survival, proliferation, and apoptosis. Inhibition of IKKβ is explored as a therapeutic strategy for inflammatory diseases and cancer.

Other names
IKBKBIKK2
02

Mechanism of action

Inhibition of IKKβ prevents phosphorylation of IκBs, leading to suppression of NF-κB activation and downstream inflammatory gene expression.

03

Biological functions

Signal transductionImmune responseInflammationCell survivalCell proliferationApoptosis
04

Disease associations

CancerInflammationObesityInsulin resistance/diabetes mellitus type IICardiovascular disease
05

Safety considerations

Potential for immunosuppressionOff-target effects on other kinases

Beyond the preview

Go deeper on Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (IKKβ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call